Stellate ganglion block

1. Introduction

Stellate ganglion block, also designated as a cervicothoracic sympathetic block, is a targeted interventional procedure providing diagnostic and therapeutic sympathetic interruption to the ipsilateral head, neck, upper extremity, and upper thoracic viscera. First described in the early twentieth century as a blind landmark-guided technique, the procedure has transitioned through fluoroscopic validation to modern high-resolution ultrasound guidance. Real-time ultrasound visualization represents the current clinical standard of care, allowing direct identification of the fascial compartments, vascular corridors, esophagus, and neural structures while minimizing life-threatening complications.

High-Yield Summary

• Primary Indications: Complex Regional Pain Syndrome (CRPS) Types I and II of the upper extremity, acute peripheral vascular insufficiency (refractory Raynaud’s phenomenon, frostbite, accidental intra-arterial injection), refractory post-traumatic stress disorder (PTSD), and refractory ventricular arrhythmias (ventricular electrical storm).
• Target Landmark: Chassaignac’s tubercle (the prominent anterior tubercle of the C6 transverse process) rather than C7. The vertebral artery at C7 courses anteriorly, unprotected by a bony transverse foramen, and the apical pleura rises toward the C7-T1 junction, making direct C7 needle targeting hazardous. Local anesthetic injected deep to the prevertebral fascia at C6 tracks caudally to bathe the stellate ganglion at C7-T1.
• Critical Ultrasound Rule: The needle tip must breach the prevertebral fascia and position strictly on the anterior epimysium of the longus colli muscle under direct in-plane lateral-to-medial visualization. Intramuscular deposition into the longus colli muscle impairs fascial fluid spread, causing high injection pressures, severe post-procedural neck pain, and block failure.
• Critical Volume Constraint: Ultrasound-guided hydrodissection achieves complete sympatholysis with 4 to 5 mL of local anesthetic. High-volume administration (8 to 10 mL or greater) increases the incidence of collateral blockade, including recurrent laryngeal nerve palsy, phrenic nerve paresis, and brachial plexus sensory-motor impairment.

2. Pertinent Anatomy

Anatomic Formation and Morphology

The cervicothoracic ganglion, commonly termed the stellate ganglion, represents the anatomical fusion of the inferior cervical sympathetic ganglion and the first thoracic (T1) sympathetic ganglion. This coalescence occurs in approximately 80% of individuals. In the remaining 20%, the inferior cervical and first thoracic ganglia persist as discrete entities connected by an interganglionic sympathetic cord. In select individuals, the second thoracic (T2) ganglion also coalesces into this complex. The ganglion typically exhibits an oval, fusiform, or multi-pointed star-shaped morphology. In adults, its dimensions average 2.0 to 2.5 cm in length, 0.8 to 1.0 cm in width, and 0.5 cm in anteroposterior depth.

Anatomical Location and Fascial Compartments

The stellate ganglion lies in the lower neck and thoracic inlet, positioned anterior to the neck of the first rib and the transverse process of the C7 vertebra, extending inferiorly toward the apex of the lung. Cranially, the cervical sympathetic chain ascends on the anterior surface of the longus colli and longus capitis muscles.

The relationship to the deep cervical fascial layers dictates local anesthetic dispersion. The deep cervical fascia divides into three layers: superficial (investing), middle (pretracheal), and deep (prevertebral). The stellate ganglion and the cervical sympathetic chain reside deep to the prevertebral fascia, embedded within loose connective tissue immediately overlying the prevertebral musculature (longus colli). Anteriorly, the carotid sheath (containing the common carotid artery, internal jugular vein, and vagus nerve) lies separated from the prevertebral space by the retrovisceral (retropharyngeal) space. Caudally, the prevertebral fascia continues into the thorax as the endothoracic fascia, providing a continuous conduit for downward fluid tracking from C6 to the C7-T1 junction.

Neural Pathways and Rami Communicantes

Preganglionic sympathetic fibers destined for the head, neck, and upper limb originate from the intermediolateral horn cells of the upper thoracic spinal cord (T1-T6 segments, predominantly T2-T4 for the upper limb). These myelinated axons exit through ventral roots, traverse white rami communicantes, enter the sympathetic trunk, and ascend to synapse within the stellate ganglion, middle cervical ganglion, and superior cervical ganglion.

Postganglionic unmyelinated C-fibers exit the stellate ganglion through gray rami communicantes to join the ventral rami of the C7, C8, and T1 spinal nerves, contributing sympathetic innervation to the brachial plexus. Efferent branches contribute to:

• The vertebral plexus, ascending along the vertebral artery to supply intracranial and posterior fossa vasculature.
• Perivascular plexuses investing the subclavian and axillary arteries, governing vasomotor and sudomotor tone throughout the upper extremity.
• Inferior cervical cardiac nerves, projecting caudally into the deep cardiac plexus to regulate chronotropy, dromotropy, and inotropy.
• Ascending sympathetic trunks supplying cephalic structures, including the pupillary dilator muscle, superior tarsal muscle (Müller’s muscle), facial sweat glands, and cutaneous arteriolar beds.

Neighboring Critical Neurovascular Structures

Safe procedural execution requires exact spatial mapping of adjacent structures at risk:

• Vertebral Artery Corridor: The vertebral artery arises from the subclavian artery and ascends anterior to the transverse process of C7 before entering the transverse foramen of C6 in approximately 90% to 93% of patients. Consequently, at the C7 level, the vertebral artery is completely exposed anteriorly without bony coverage, lying directly in the path of an unguided needle. Even at C6, anatomical variants exist where the artery enters at C5 or C4, or exhibits tortuous medial loops over the longus colli.
• Carotid Sheath: The common carotid artery, internal jugular vein, and vagus nerve are situated directly anterior and anterolateral to the longus colli muscle. Deep needle trajectory or blind compression maneuvers risk carotid or internal jugular vascular penetration.
• Inferior Thyroid Artery: Arising from the thyrocervical trunk, this vessel ascends and arches medially across the anterior aspect of the longus colli muscle and sympathetic trunk at the C6-C7 level to reach the lower pole of the thyroid gland. It represents a frequent source of unrecognized hematoma formation during in-plane needle advancement.
• Recurrent Laryngeal Nerve: Ascending within the tracheoesophageal groove on the medial aspect of the carotid sheath and thyroid gland, this nerve is vulnerable to medial local anesthetic overflow, leading to transient vocal cord paresis and hoarseness.
• Phrenic Nerve: Descending along the anterior surface of the anterior scalene muscle within its own investing layer of prevertebral fascia, the phrenic nerve is situated lateral to the target plane. Lateral tracking of excessive local anesthetic volumes causes transient ipsilateral diaphragmatic paralysis.
• Pleural Cupula: The cervical pleura and apical lung cupula ascend 2 to 3 cm superior to the clavicle and first rib, situated immediately posterior and lateral to the stellate ganglion at the C7-T1 level. Blind or excessively caudal approaches risk pleural puncture and secondary pneumothorax.
• Esophagus: Positioned posterior to the trachea, the esophagus regularly curves laterally toward the left side of the neck at the C6 level. In up to 25% of individuals, the left lateral esophageal border projects beyond the margin of the trachea and overlies the medial border of the longus colli muscle, placing it directly in line with needle trajectory during left-sided blocks.

3. Pathophysiology & Mechanism of Action

Sympathetically Maintained Pain (SMP) vs Sympathetically Independent Pain (SIP)

Neuropathic pain syndromes, particularly Complex Regional Pain Syndrome (CRPS), frequently exhibit an autonomic component designated as Sympathetically Maintained Pain (SMP). Under physiological conditions, primary sensory nociceptors (A-delta and C fibers) do not respond to sympathetic efferent activity or circulating catecholamines. Following tissue or nerve trauma, pathological neuroplasticity induces ectopic adrenergic sensitivity on primary afferent neurons.

This adrenergic coupling arises through denervation supersensitivity and de novo expression of functional alpha-1 and alpha-2 adrenoceptors on nociceptive membranes, as well as sprout formation by postganglionic sympathetic fibers around dorsal root ganglion cell bodies. Consequently, physiological sympathetic discharge or endogenous catecholamine release directly depolarizes nociceptors, sustaining hyperalgesia and allodynia.

Interruption of this efferent loop via stellate ganglion block distinguishes SMP from Sympathetically Independent Pain (SIP). If successful sympatholysis (verified by objective Horner’s syndrome and limb warming) eliminates spontaneous pain and mechanical allodynia, the condition is confirmed as SMP. If objective sympatholysis fails to relieve pain, the pain is sympathetically independent, driven by primary central sensitization or structural axonal damage that will not respond to serial sympathetic neurolysis.

Microvascular & Hemodynamic Effects

Postganglionic sympathetic terminals release norepinephrine, neuropeptide Y, and adenosine triphosphate (ATP), which maintain vascular smooth muscle contraction through alpha-1 and alpha-2 receptors. Tonic sympathetic outflow preserves baseline arteriolar vascular resistance.

Pharmacological blockade of the stellate ganglion removes this tonic vasoconstriction across the ipsilateral head, neck, and upper extremity. The resulting hemodynamic response comprises:

• Immediate arteriolar smooth muscle relaxation and decreased peripheral vascular resistance.
• Significant augmentation of cutaneous and deep tissue capillary perfusion.
• Rapid opening of precapillary sphincters and arteriovenous anastomoses in digital pulp beds, recorded objectively as a temperature rise (greater than or equal to 1.5°C) and increased plethysmographic pulse wave amplitude.
• Enhanced microvascular oxygenation and clearance of local algogenic and inflammatory metabolites (bradykinin, substance P, calcitonin gene-related peptide).

Neuroinflammatory and Central Neuromodulation

Beyond vasomotor control, the sympathetic nervous system interacts bidirectionally with the immune system and central neural networks:

• Neuroinflammatory Modulation: Postganglionic sympathetic varicosities interface with tissue macrophages, mast cells, and endothelial cells. Elevated norepinephrine promotes the release of pro-inflammatory cytokines, including tumor necrosis factor-alpha (TNF-alpha), interleukin-1 beta (IL-1beta), and nerve growth factor (NGF). Stellate ganglion blockade attenuates this cytokine cascade, reducing peripheral neurogenic inflammation.
• Central Autonomic and Limbic Modulation: Perivascular sympathetic fibers ascending along the carotid and vertebral arterial trees project to the locus coeruleus, amygdala, insular cortex, and hypothalamus. Excessive sympathetic activity drives a feed-forward cycle of hyperarousal and limbic hyper-reactivity characteristic of post-traumatic stress disorder (PTSD). Anesthetic blockade of the stellate ganglion transiently downregulates central norepinephrine synthesis in the locus coeruleus and resets the dysregulated hypothalamic-pituitary-adrenal (HPA) axis.
• Cardiac Electrophysiological Stabilization: Sympathetic projections from the stellate ganglia modulate cardiac ventricular electrophysiology. Pathological left-sided or asymmetric stellate hyperactivity shortens ventricular refractory periods and lowers the threshold for life-threatening ventricular arrhythmias. Temporary blockade suppresses arrhythmogenic sympathetic surges, terminating refractory ventricular tachycardia and ventricular fibrillation storm.

4. Natural History & Clinical Indications

Established Clinical Indications

• Complex Regional Pain Syndrome (CRPS Types I and II): SGB serves as both a diagnostic validation tool for sympathetically maintained pain and a therapeutic modality to enable active physical therapy and functional extremity restoration.
• Acute Vascular Insufficiency and Peripheral Ischemia: Refractory Raynaud’s phenomenon with digital ulceration or threatened gangrene; acute frostbite injuries of the digits (reversing vasospasm, improving microvascular perfusion, and minimizing tissue necrosis); accidental intra-arterial injection of cytotoxic or vasoactive compounds; upper extremity arterial thromboembolism or post-revascularization vasospasm.
• Neuropathic and Post-Infectious Pain Syndromes: Acute herpes zoster ophthalmicus or upper extremity distribution, reducing acute pain intensity and lowering the transition rate to post-herpetic neuralgia.
• Refractory Ventricular Electrical Storm: Recurrent sustained ventricular tachycardia or ventricular fibrillation refractory to antiarrhythmic infusions, deep sedation, and catheter ablation.
• Treatment-Refractory Post-Traumatic Stress Disorder (PTSD): Severe autonomic hyperarousal, night terrors, and treatment-resistant hypervigilance refractory to standard pharmacotherapy and trauma-focused psychotherapy.

Contraindications

Rigorous pre-procedural risk assessment identifies conditions precluding safe intervention:

• Absolute Contraindications: Patient refusal or inability to provide informed consent; active localized skin or soft-tissue infection at the cervical injection site; systemic sepsis or uncontained bacteremia; severe uncorrected coagulopathy (INR greater than or equal to 1.5, severe thrombocytopenia with platelet count below 50,000/mcL, or concurrent therapeutic systemic anticoagulation without appropriate cessation intervals); recent acute myocardial infarction (less than 3 months) or high-grade cardiac conduction block without a functioning pacemaker.
• Relative Contraindications: Pre-existing contralateral vocal cord paralysis or phrenic nerve palsy (collateral block on the functional side risks acute bilateral vocal cord closure or bilateral diaphragmatic paralysis causing respiratory arrest); severe baseline pulmonary disease (end-stage COPD, severe pulmonary fibrosis, advanced ALS) where inadvertent ipsilateral phrenic nerve blockade could precipitate acute ventilatory failure; prior extensive anterior cervical spine surgery (such as anterior cervical discectomy and fusion), radiation therapy, or massive cervical goiter with distorted fascial planes; known allergy to amide local anesthetics.

5. Clinical Presentation & Pre-Procedural Evaluation

Patient History & Symptom Triad

Candidates evaluated for diagnostic or therapeutic stellate ganglion block characteristically report a clinical triad reflecting sensory, autonomic, and motor/trophic pathology:

• Disproportionate Sensory Pain: Intense, non-dermatomal, deep burning, throbbing, or aching pain out of proportion to the inciting event. Patients describe hyperalgesia (amplified pain to noxious stimuli) and severe allodynia (pain provoked by innocuous stimuli such as light clothing or a breeze).
• Autonomic Vasomotor and Sudomotor Instability: Temperature asymmetries across bilateral limbs, rapid skin color transitions (mottled, dusky cyanotic, or bright erythematous), and localized hyperhidrosis or hypohidrosis.
• Motor and Trophic Deterioration: Decreased range of motion, muscle weakness, localized tremors, or dystonic posturing of the digits. Trophic changes include coarse or brittle nail beds, loss of distal hair growth, dry atrophic skin, or non-pitting soft tissue edema.

Physical Examination & Objective Baselines

• Standardized Cutaneous Thermometry: Bilateral palmar and volar digital pulp skin temperatures must be recorded in an environmentally controlled room (ambient temperature 22°C to 24°C) following an acclimatization period of 15 to 20 minutes. A baseline discrepancy between limbs is documented.
• Quantitative Sensory and Provocative Testing: Systematic mapping of mechanical allodynia using a cotton wisp or camel-hair brush, pinprick hyperalgesia using standardized monofilaments, and cold/warm thermal sensitivity testing.
• Objective Hemodynamic Assessment: Baseline pulse volume recording (PVR) or digital photoplethysmography is applied to quantify peripheral pulse amplitude.
• Comprehensive Airway and Neurological Examination: Evaluation of baseline phonation, vocal cord stability, cervical range of motion, and Mallampati score. Any pre-existing baseline hoarseness warrants pre-procedural laryngoscopic examination to confirm bilateral vocal cord mobility.

6. Diagnostic Imaging & Ultrasound Sonoanatomy

Ultrasound Sonoanatomy at C6

High-frequency linear array ultrasonography (10 to 15 MHz) constitutes the gold-standard imaging modality for stellate ganglion blockade:

• Level Differentiation: The C6 transverse process serves as the primary bony anchor. It is distinguished from adjacent cervical levels by its prominent, towering anterior tubercle (Chassaignac’s tubercle) and smaller posterior tubercle, producing a characteristic bicuspid “camel hump” profile on transverse cross-sectional view.
• Contrast with C7: Sliding the transducer caudally to C7 demonstrates a rudimentary or completely absent anterior tubercle, presenting a flat, monocuspid posterior tubercle profile. Importantly, the vertebral artery is consistently observed at C7 pulsating anterior to the transverse process, unprotected by a transverse foramen.
• Muscular Architecture: The longus colli muscle appears as an oval hypoechoic structure resting directly upon the anterior surface of the C6 vertebral body, medial to the anterior tubercle. The longus capitis muscle lies superficial to the longus colli. The scalenus anterior muscle attaches to the tip of Chassaignac’s tubercle laterally.
• Fascial Plane: The echogenic prevertebral fascia covers the anterior surface of the longus colli muscle. The true target plane is the virtual sub-fascial space situated immediately deep to the prevertebral fascia and superficial to the anterior epimysium of the longus colli.
• Vascular Interrogation via Color Doppler: Continuous color Doppler must be engaged to map the common carotid artery, internal jugular vein, vertebral artery, and the ascending cervical or inferior thyroid arteries. The inferior thyroid artery frequently loops across the anterior aspect of the longus colli between the carotid sheath and prevertebral fascia.
• Visceral Structures: On the left side of the neck, the esophagus is identified posteromedial to the carotid artery and deep to the thyroid gland, often displaying mucosal acoustic shadowing and active peristaltic movement during swallowing.

Fluoroscopic Anatomy

While ultrasound has largely supplanted fluoroscopy for soft-tissue discrimination, fluoroscopy remains a recognized guidance method in specific institutional settings:

• Anatomical Target: On an anterior-posterior (AP) fluoroscopic projection, the target is the junction between the vertebral body and the base of the transverse process of C6.
• Oblique View: A 20 to 30-degree ipsilateral oblique projection verifies that the needle tip rests against the bony cortex of the uncinate process at C6, safely distant from the intervertebral foramen.
• Contrast Confirmation: Injection of 0.5 to 1.0 mL of non-ionic water-soluble radiopaque contrast under real-time fluoroscopic or digital subtraction angiography (DSA) is mandatory. A successful block reveals a linear, craniocaudal spread pattern within the prevertebral fascial space. Intravascular uptake (manifesting as rapid contrast washout into the vertebral, carotid, or deep cervical vessels) or peri-neural root sleeve filling (myelographic silhouette indicating intrathecal or epidural entry) demands immediate needle repositioning.

7. Diagnostic Criteria & Classification

Diagnostic accuracy and procedural efficacy depend upon standardized clinical and physiological criteria.

Following intervention, objective physiological criteria establish the completeness of cervical and upper extremity sympatholysis.

8. Procedural Technique & Step-by-Step Execution

Pre-Procedural Setup & Monitoring

Standard ASA monitoring (continuous electrocardiography, pulse oximetry, and non-invasive blood pressure cycling every 3 to 5 minutes) is mandatory. Intravenous access must be established in the contralateral upper extremity prior to positioning. Resuscitation equipment (bag-valve-mask, laryngoscope, endotracheal tubes, suction) and rescue medications, including 20% lipid emulsion (Intralipid), epinephrine, atropine, and benzodiazepines, must be immediately accessible. Aseptic preparation entails chlorhexidine gluconate with 70% isopropyl alcohol skin antisepsis, sterile surgical draping, and a dedicated sterile acoustic probe sheath.

Patient Positioning

The patient is positioned supine on a procedure table with a small shoulder roll placed beneath the upper thoracic spine to facilitate modest cervical extension. The head is gently rotated 15 to 30 degrees toward the contralateral side. Excessive neck extension or rotation must be avoided, as it collapses the internal jugular vein and draws the carotid sheath directly over the anterior tubercle of C6. The patient is instructed to breathe quietly and avoid speaking, swallowing, or coughing once needle advancement begins.

Real-Time Ultrasound-Guided In-Plane Technique

Execution follows a disciplined sequential protocol:

• Step 1: Acoustic Survey and Trajectory Planning. Place the high-frequency linear transducer transversely at the cricoid cartilage level (approximating C6). Confirm Chassaignac’s tubercle. Activate color Doppler to identify the carotid artery, internal jugular vein, and inferior thyroid artery. Identify the esophagus and longus colli muscle.
• Step 2: Cutaneous Anesthesia. Infiltrate 0.5 to 1.0 mL of 1% plain lidocaine at the needle entry site lateral to the transducer footprint using a 30-gauge needle.
• Step 3: In-Plane Lateral-to-Medial Needle Insertion. Introduce a 22- to 25-gauge, 50-mm short-bevel or echogenic needle in-plane from lateral to medial. Direct the needle between the carotid sheath medially and the anterior tubercle of C6 laterally, visualizing the entire shaft and tip continuously throughout advancement.
• Step 4: Fascial Breach and Target Seeding. Advance the needle tip through the echogenic prevertebral fascia until the bevel rests on the anterior epimysium of the longus colli muscle. The needle must not penetrate into the substance of the longus colli muscle.
• Step 5: Verification and Hydrolocalization. Perform a meticulous negative aspiration for blood and cerebrospinal fluid. Inject a test aliquot of 0.5 mL of local anesthetic or normal saline under direct real-time visualization. Observe the hypoechoic injectate lifting the prevertebral fascia away from the longus colli muscle surface, demonstrating unhindered longitudinal fascial hydrodissection.
• Step 6: Incremental Local Anesthetic Delivery. Administer the remaining volume slowly in 1- to 1.5-mL increments over 60 to 90 seconds, repeating gentle aspiration before each increment. Observe continuous fluid spread without high-pressure tissue distension or vascular blanching.

Injectate Pharmacology & Dosing

Local anesthetic selection is tailored to the procedural objective:

• Diagnostic Interventions: 1% to 2% lidocaine (onset 3 to 5 minutes, duration 1 to 2 hours) is preferred to confirm sympathetically maintained pain without causing prolonged motor or cranial nerve deficits.
• Therapeutic Interventions: 0.2% to 0.25% ropivacaine or 0.25% bupivacaine (onset 10 to 15 minutes, duration 6 to 12 hours) provides sustained sympathetic blockade with favorable cardiac safety profiles.
• Volume Strategy: A strict volume of 4 to 5 mL is utilized under real-time ultrasound guidance. Historical blind volumes of 10 to 15 mL are unnecessary, as ultrasound allows precise sub-fascial localization, eliminating volume-dependent spread to the phrenic and recurrent laryngeal nerves.
• Adjuvant Agents: Corticosteroids (such as dexamethasone 4 mg) or alpha-2 agonists (clonidine 0.5 mcg/kg) may be considered in chronic neuropathic states. Neurolytic agents (phenol or absolute alcohol) are contraindicated in non-malignant conditions due to disastrous risks of permanent Horner’s syndrome, brachial plexus neuritis, and tissue necrosis.

9. Clinical Outcomes & Efficacy

CRPS Pain Reduction & Functional Restoration

In patients with confirmed sympathetically maintained pain (SMP), successful stellate ganglion blockade produces immediate reductions in pain visual analogue scale (VAS) scores by greater than or equal to 50%. The primary clinical objective is not permanent sensory anesthesia, but opening a critical therapeutic window for active physical and occupational rehabilitation. Mobilization during the sympathetic blockade period reverses joint stiffness, mitigates edema, and disrupts the vicious cycle of disuse and trophic degradation. Early intervention within the first 3 to 6 months of CRPS onset yields significantly higher complete functional recovery rates compared to chronic intervention beyond 12 months.

Vascular Salvage & Ischemia Outcomes

In acute digital ischemia, severe Raynaud’s phenomenon, and frostbite, stellate ganglion blockade rapidly restores digital perfusion pressures and microvascular capillary blood flow. Quantitative studies demonstrate rapid elevation of digital pulp temperatures by 2.0°C to 4.5°C within 15 minutes of injection. In acute frostbite protocols, emergency sympathetic blockade within 24 to 48 hours of rewarming significantly reduces the final level of digital demarcation and tissue loss, decreasing amputation rates.

Neuromodulatory & Psychiatric Outcomes

In treatment-refractory PTSD, randomized controlled trials demonstrate that stellate ganglion blockade (predominantly right-sided or bilateral sequential blocks) achieves clinically meaningful and sustained reductions in Clinician-Administered PTSD Scale for DSM-5 (CAPS-5) scores. Improvements in hyperarousal, night sweats, startled responses, and sleep architecture are observed within 24 hours, often persisting for several months. In cardiac ventricular electrical storm, emergency left stellate ganglion blockade or continuous catheter infusion reliably suppresses recalcitrant ventricular tachycardia surges, stabilizing patients for definitive electrophysiological mapping or cardiac transplantation.

10. Complications & Neurovascular Danger Zones

Complications range from expected physiological manifestations to catastrophic neurovascular emergencies.

Neurovascular Danger Zone Mapping

• Vertebral Artery Corridor: Maximum danger exists at C7, where the artery lacks bony transverse foramen shielding. At C6, anomalous entries or medial loops over the longus colli occur in up to 7% of individuals. Direct intra-arterial injection of as little as 0.25 to 0.5 mL of local anesthetic produces immediate grand mal seizures, coma, and respiratory arrest due to direct posterior circulation delivery into the brainstem.
• Carotid Sheath and Jugular Venous System: Accidental puncture of the common carotid artery generates large cervical hematomas capable of acute airway compromise. Rapid intravenous uptake into the internal jugular vein precipitates systemic local anesthetic toxicity (LAST).
• Esophageal Wall: On the left side of the neck, esophageal lateral deviation beyond the tracheal border exposes the mucosal lumen to inadvertent transfixion. Esophageal breach introduces oral flora into the deep prevertebral fascial space, causing mediastinitis and retropharyngeal abscess.
• Apical Pleural Cupula: Caudal needle angulation past the C6-C7 intervertebral disc risks traversing the apex of the lung. Pleural violation triggers pneumothorax, which may rapidly convert to tension pneumothorax under positive-pressure ventilation.

11. Pearls and Pitfalls

Master Procedural Pearls

• Confirmatory C7 Sweep: Always initiate ultrasound scanning at the lower cervical base to identify C7 (monocuspid posterior tubercle, absent anterior tubercle, pulsating exposed vertebral artery), then slide cephalad to bring Chassaignac’s tubercle at C6 into view. This definitive maneuver prevents inadvertent C7 puncture.
• Dynamic Swallowing Assessment: Before needle insertion, have the patient swallow under active ultrasound visualization. This delineates the dynamic borders of the esophagus, especially on the left side. Instruct the patient firmly not to speak or swallow during needle advancement.
• Sub-fascial Hydrodissection Endpoint: Ensure the needle tip creates a distinct fluid lens peeling the prevertebral fascia away from the anterior epimysium of the longus colli. If fluid collects within the muscle belly (expanding muscle fibers), stop immediately and withdraw 0.5 mm into the true sub-fascial plane.
• Fractional Injection Protocol: Employ a low-volume syringe (3 to 5 mL) connected to flexible extension tubing. An assistant aspirates before every 1 mL injection while the operator maintains steady two-handed probe and needle stabilization.

Critical Pitfalls & Emergency Rescue Maneuvers

• Local Anesthetic Systemic Toxicity (LAST) Rescue Protocol: Immediate recognition of early neurological symptoms (perioral numbness, tinnitus, metallic taste, visual changes) or sudden seizures and cardiovascular collapse. Cease injection immediately, call the resuscitation team, secure the airway with 100% oxygen, and initiate 20% lipid emulsion (Intralipid): administer an IV bolus of 1.5 mL/kg over 2 to 3 minutes, followed by an infusion of 0.25 mL/kg/min.
• Total Spinal Anesthesia Rescue: Caused by unrecognized dural cuff puncture or intrathecal injection through the intervertebral foramen. Manifests as rapid ascending motor block, aphonia, dilated unreactive pupils, profound hypotension, bradycardia, and apnea. Management requires immediate endotracheal intubation, mechanical ventilation with 100% oxygen, aggressive IV fluid resuscitation, and intravenous vasopressors (ephedrine, phenylephrine, or epinephrine). Support hemodynamics until local anesthetic is cleared.
• Esophageal Perforation Management: If the needle pierces the esophageal lumen, immediately abort the procedure, discard the needle, initiate prophylactic broad-spectrum oral and intravenous antibiotics, and monitor for signs of retropharyngeal space infection or mediastinitis.

12. Current Controversies

Ultrasound vs Fluoroscopy vs Blind Landmark Technique

Historical blind landmark techniques relied on manual palpation of Chassaignac’s tubercle and compression of the carotid sheath. However, anatomic variations, vascular tortuosity, and esophageal deviation render blind palpation inherently unsafe, with historical complication rates exceeding 10% to 15%. Fluoroscopy visualizes bony landmarks and radiopaque contrast spread, ensuring avoidance of intravascular runoff, but cannot visualize soft-tissue structures such as the vertebral artery at C7, the inferior thyroid artery, or the esophagus. Real-time ultrasound is now widely regarded as the gold standard, offering direct continuous visualization of all soft-tissue danger zones and allowing immediate detection of sub-fascial hydrodissection.

Volume Controversy: 4-5 mL vs 10 mL

Traditional blind and fluoroscopic protocols mandated large injectate volumes (10 to 15 mL) based on the assumption that extensive volume was required to track caudally from C6 to the C7-T1 junction. However, imaging and anatomical studies confirm that 4 to 5 mL deposited precisely deep to the prevertebral fascia spreads reliably to C7-T1. Larger volumes (greater than 8 to 10 mL) dramatically increase non-target collateral spread into the epidural space, brachial plexus, recurrent laryngeal nerve, and phrenic nerve without improving sympatholysis. Modern practice establishes 4 to 5 mL as the optimal therapeutic ceiling for ultrasound-guided blocks.

Neurolysis / Radiofrequency vs Serial Local Anesthetic Injections

Chemical neurolysis (phenol or absolute alcohol) or high-temperature thermal radiofrequency ablation (RFA) of the stellate ganglion has been proposed for permanent sympathetic interruption. However, destructive techniques carry unacceptable risks of permanent Horner’s syndrome, post-ganglionectomy deafferentation neuralgia, severe brachial plexus neuritis, and tissue necrosis. In non-malignant pain such as CRPS, thermal or chemical neurolysis is strongly discouraged. Serial local anesthetic blocks, pulsed radiofrequency neuromodulation, or surgical endoscopic thoracic sympathectomy (ETS) for refractory hyperhidrosis or vascular conditions represent safer alternatives.

Emerging Psychiatric Indications

The application of stellate ganglion block for treatment-resistant PTSD and anxiety disorders has generated significant clinical debate. While observational studies and randomized sham-controlled trials have demonstrated significant reductions in CAPS-5 scores and autonomic hyperarousal, questions remain regarding durability, optimal laterality (right-sided vs bilateral), and integration with standard psychiatric care. Sympathetic blockade acts as a biological reset button that dampens amygdala and sympathetic overdrive, facilitating more effective participation in trauma-focused cognitive therapy.

13. Evidence-Based Synthesis

Modern clinical decision-making is grounded in high-quality randomized controlled trials and prospective registry analyses, corroborated by seminal biomechanical and anatomical descriptions.

14. References

• Tian Y, Hu Y, Hu T et al. Stellate Ganglion Block Therapy for Complex Regional Pain Syndrome: A Systematic Review and Meta-Analysis. Pain Physician. 2024. doi:PMID:38805523 [Level I: Systematic Review / Meta-Analysis]
• Narouze S. Ultrasound-guided stellate ganglion block: safety and efficacy. Curr Pain Headache Rep. 2014. doi:10.1007/s11916-014-0424-5 [Level IV: Clinical Case Series / Cohort Study]
• Kapral S, Krafft P, Gosch M et al. Ultrasound imaging for stellate ganglion block: direct visualization of puncture site and local anesthetic spread. A pilot study. Reg Anesth. 1995. doi:PMID:7577781 [Level I: Randomized Controlled Trial]
• Harden RN, Oaklander AL, Burton AW et al. Complex regional pain syndrome: practical diagnostic and treatment guidelines, 4th edition. Pain Med. 2013. doi:10.1111/pme.12033 [Level IV: Clinical Case Series / Cohort Study]
• Xiang XB, Wu YY, Fang Z et al. Stellate ganglion block for visceral pain in elderly patients undergoing video-assisted thoracoscopic lung cancer surgery: a randomized, controlled trial. Int J Surg. 2024. doi:10.1097/JS9.0000000000001867 [Level I: Randomized Controlled Trial]

15. Master Class Pro-Tip

Prior to advancing the needle at C6, always execute the “C7-to-C6 acoustic verification maneuver”: slide the linear transducer caudally to identify the solitary, flattened posterior tubercle of C7 and the pulsatile vertebral artery lying anteriorly unprotected by bone. Once C7 is confirmed, slide cephalad to bring the prominent Chassaignac’s tubercle into view, establishing the C6 level beyond doubt. Under direct in-plane visualization from lateral to medial, advance the needle tip strictly through the prevertebral fascia onto the anterior epimysium of the longus colli. Verify the sub-fascial plane with 0.5 mL of saline: hydrodissection must gently peel the fascia upward while the muscle fibers remain crisp and unexpanded. Depositing precisely 4 to 5 mL in this virtual plane ensures gravity and fascial continuity drive the local anesthetic caudally to envelop the stellate ganglion at C7-T1, achieving complete sympatholysis while completely eliminating the risks of phrenic and recurrent laryngeal nerve overflow.

Master Class Procedural Pearl